These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27020584)

  • 1. Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy.
    Mohiuddin K; Dorer R; El Lakis MA; Hahn H; Speicher J; Hubka M; Low DE
    Ann Surg Oncol; 2016 Aug; 23(8):2673-8. PubMed ID: 27020584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.
    Nelson DB; Dhupar R; Katkhuda R; Correa A; Goltsov A; Maru D; Sepesi B; Antonoff MB; Mehran RJ; Rice DC; Vaporciyan AA; Davila M; Davila R; Betancourt S; Ajani J; Hofstetter WL
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):406-413.e3. PubMed ID: 29605441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma.
    Noguchi H; Naomoto Y; Kondo H; Haisa M; Yamatsuji T; Shigemitsu K; Aoki H; Isozaki H; Tanaka N
    Surg Laparosc Endosc Percutan Tech; 2000 Dec; 10(6):343-50. PubMed ID: 11147906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
    Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
    World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.
    Wang S; Huang Y; Xie J; Zhuge L; Shao L; Xiang J; Zhang Y; Sun Y; Hu H; Chen S; Lerut T; Luketich JD; Zhang J; Chen H
    Surg Endosc; 2018 Mar; 32(3):1441-1448. PubMed ID: 28916920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era.
    Dickinson KJ; Wang K; Zhang L; Allen MS; Cassivi SD; Nichols FC; Shen R; Wigle DA; Blackmon SH
    Ann Thorac Surg; 2017 Mar; 103(3):890-897. PubMed ID: 27964921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
    Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
    Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endoscopic resection in early-stage esophageal adenocarcinoma: Esophagectomy is associated with improved survival in patients presenting with clinical stage T1bN0 disease.
    Swanson J; Littau M; Tonelli C; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
    Surgery; 2023 Mar; 173(3):693-701. PubMed ID: 36273971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia.
    Podboy A; Kolahi KS; Friedland S; Louie CY
    Dig Endosc; 2020 Mar; 32(3):346-354. PubMed ID: 31306525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience.
    Huntington JT; Walker JP; Meara MP; Hazey JW; Melvin WS; Perry KA
    Surg Endosc; 2015 Aug; 29(8):2121-5. PubMed ID: 25472745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
    Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
    Ramay FH; Vareedayah AA; Visrodia K; Iyer PG; Wang KK; Eluri S; Shaheen NJ; Reddy R; Martin LW; Greenwald BD; Edwards MA
    Ann Surg Oncol; 2019 Mar; 26(3):714-731. PubMed ID: 30607765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.